Life Cycle Management Strategies - Optimizing revenues and defending generic competition

www.MarketResearchReports.com

Life Cycle Management Strategies - Optimizing

revenues and defending generic

competition

Category : Pharma & Healthcare

All logos and Images mentioned on this slide belong to their respective owners.


Introduction to Report

Launch Date: July 2, 2015

Number of Pages: 100

Geography Coverage: Global

Available Format: PDF

Price For Single User License: USD 2,995

Price For Site User License: USD 5,990

Price For Global User License: USD 8,985

Delivery Time: Within 24 Hours (During Working Days)


About the Report

Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies.

The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.


Scope

Introduction of LCM and product life cycle

Objectives of LCM and factors impacting the choice of strategies

LCM strategies depending on the way of approach

Impact of LCM strategies on sales and growth trend of selected products

Patent term extension and market exclusivity in the US and Europe

LCM strategies of pipeline drugs of key players

Keys to successful implementation of LCM strategies


Reasons to buy

Identify the key LCM strategies used by most of the pharmaceutical companies

Analyze the strategies to increase lifecycle and revenues of a drug

Gain an understanding on the implementation of multiple strategies for a single product by including case studies

Understand the operational pipeline strategies of key players


Report Coverage:

1. Executive Summary

2. Introduction

3. Developmental Strategies

4. Geographical Expansion

5. Regulatory and Legal Strategies

6. Appendix

For more details regarding Report coverage see the last slide



Company Coverage: (Partial List)

1. AbbVie

2. Actavis

3. AstraZeneca

4. Cipla

5. Gilead

6. GlaxoSmithKline

7. Gleevec

8. Janssen

9. MannKind

10. Merck

11. NovartisFor more details regarding company coverage and TOC see the last slide



Custom Research: Are you an industry professional, entrepreneur,

venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.

For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter

http://www.marketresearchreports.com/idea-center

http://www.marketresearchreports.com/subscribe-to-newsletter

http://www.marketresearchreports.com/subscribe-to-newsletter


How To Buy This Report?

Visit following URL to see Table of Content and purchase this publication:

http://mrr.cm/4tr

About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.

Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)

http://mrr.cm/4tr

http://mrr.cm/4tr

mailto:[email protected]

Life Cycle Management Strategies - Optimizing revenues and defending generic competition

Healthcare

Transcript of Life Cycle Management Strategies - Optimizing revenues and defending generic competition